BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou P, Tian S, Li J, Zhao Y, Liu W, Zhang Y, Hu Z. Paradoxes in thyroid carcinoma treatment: analysis of the SEER database 2010-2013. Oncotarget 2017;8:345-53. [PMID: 27861148 DOI: 10.18632/oncotarget.13395] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Kaliszewski K, Diakowska D, Nowak Ł, Wojtczak B, Rudnicki J. The age threshold of the 8th edition AJCC classification is useful for indicating patients with aggressive papillary thyroid cancer in clinical practice. BMC Cancer 2020;20:1166. [PMID: 33256657 DOI: 10.1186/s12885-020-07636-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Wang Z, Xia F, Feng T, Jiang B, Wang W, Li X. OTUD6B-AS1 Inhibits Viability, Migration, and Invasion of Thyroid Carcinoma by Targeting miR-183-5p and miR-21. Front Endocrinol (Lausanne) 2020;11:136. [PMID: 32256450 DOI: 10.3389/fendo.2020.00136] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
3 Yu L, Hong H, Han J, Leng SX, Zhang H, Yan X. Comparison of Survival and Risk Factors of Differentiated Thyroid Cancer in the Geriatric Population. Front Oncol 2020;10:42. [PMID: 32117715 DOI: 10.3389/fonc.2020.00042] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
4 Xia F, Jiang B, Chen Y, Du X, Peng Y, Wang W, Wang Z, Li X. Prediction of novel target genes and pathways involved in tall cell variant papillary thyroid carcinoma. Medicine (Baltimore) 2018;97:e13802. [PMID: 30572540 DOI: 10.1097/MD.0000000000013802] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
5 Pham T, Roth S, Kong J, Guerra G, Narasimhan V, Pereira L, Desai J, Heriot A, Ramsay R. An Update on Immunotherapy for Solid Tumors: A Review. Ann Surg Oncol 2018;25:3404-12. [DOI: 10.1245/s10434-018-6658-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 36] [Article Influence: 6.0] [Reference Citation Analysis]
6 Liu C, Ming J, Zeng W, Wang S, Xiong Y, Zhao Q, Yin X, Liu Z, Huang T. Unanticipated prognosis of differential thyroid cancer patients with T0 stage: analysis of the SEER database 2004-2013. Oncotarget 2017;8:70777-87. [PMID: 29050318 DOI: 10.18632/oncotarget.19988] [Reference Citation Analysis]
7 Liu FC, Lin HT, Lin SF, Kuo CF, Chung TT, Yu HP. Nationwide cohort study on the epidemiology and survival outcomes of thyroid cancer. Oncotarget 2017;8:78429-51. [PMID: 29108240 DOI: 10.18632/oncotarget.19488] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]